Medicine and medical device supply
There is no need to stockpile medicines. Medicine supply chains are secure and pharmacies remain open throughout all alert levels. We ask prescribers to prescribe normally and encourage patients not to stockpile medicines.
PHARMAC and suppliers are all working to minimise any impacts of the general supply chain and manufacturing disruptions caused by COVID-19.
Other than some funded vaccines, PHARMAC itself does not purchase or hold stocks of any medicine.
COVID-19 vaccine
New Zealand has access to 1.5 million doses of the Pfizer BioNTech COVID-19 vaccine.
Read more about the Pfizer vaccine on COVID19.govt.nz(external link)
We are part of the All-of-Government COVID-19 vaccine strategy.
Read more about the vaccine strategy on MBIE's website(external link)
-
Information for patients
What you need to know about your medicines.
-
Information for pharmacists
NPPA and lamotrigine changes to help during COVID response
-
Information for prescribers
What we've done to help you support your patients
-
Hydroxychloroquine
We've limited access to proven indications.
-
Medicines with amended access criteria
-
Dispensing frequency
Which medicines have dispensing limits
-
Current supply issues for medicines and devices
Check the medicine notices page for stock issues and discontinuations caused by COVID-19.
-
OIAs about our COVID-19 response
What we were asked and how we answered.
-
Hospital medical devices and PHARMAC
An update from the team